The peptide storage guide covers optimal conditions for maintaining potency
Tesamorelin, another modified GHRH analogue, has been characterised in clinical-trial-stage research for HIV-associated lipodystrophy (PMID 20554713)
But the population of people who have taken BPC-157 outside research settings has not been followed for the kind of duration that would resolve the question, and Kekic is unambiguous about what that means for her clinical practice
If a patient stops taking Suboxone for more than 1-2 days, returns to opioid use, then tries to restart Suboxone, the patient will likely experience sudden and severe opioid withdrawal symptoms that mimic flu-like symptoms (muscle aches, nausea, vomiting, sweating, chills, tremors and diarrhea)